Details

Notice: Guidance Document: Tamper-resistance Formulations of Opioid Drug Products - Canada.ca

Metadata and links for an archived snapshot.

Source
Health Canada
Date
Apr 18, 2025 · edition #1
Timestamp
2025-04-18T22:29:47.621Z
Language
en
ID
145766
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview